Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
TG Therapeutics (TGTX)
NASDAQ:TGTX
Holding TGTX?
Track your performance easily
TG Therapeutics (TGTX) Ownership Overview
1.09% Insiders
15.92% Mutual Funds
0.20% Other Institutional Investors
24.64% ETFs
58.14% Public Companies and Individual Investors
The ownership structure of TG Therapeutics (TGTX) stock is a mix of institutional, retail, and individual investors. Approximately 40.77% of the company’s stock is owned by Institutional Investors, 1.09% is owned by Insiders, and 58.14% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jan 07, 2025 | Sean Power Cfo | xxxxxxxxxxxxx | $629297 |
| Nov 12, 2024 | Laurence Charney Director | xxxxxxxxxxxxx | $754750 |
| Nov 12, 2024 | Sagar Lonial Director | xxxxxxxxxxxxx | $152200 |
| Nov 07, 2024 | Yann Echelard Director | xxxxxxxxxxxxx | $489600 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $31436 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $268470 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $387268 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1517964 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 15,717,619 | Institution | 10.10% | 474,357,741 | |
| 13,781,907 | Institution | 8.85% | 415,937,953 | |
| 11,778,823 | Institution | 7.57% | 355,484,878 | |
| 5,910,376 | Institution | 3.80% | 178,375,148 | |
| 2,565,322 | Institution | 1.65% | 77,421,418 | |
| 1,731,392 | Institution | 1.11% | 52,253,411 | |
| 1,525,589 | Institution | 0.98% | 46,042,276 | |
| 1,436,749 | Institution | 0.92% | 43,361,085 | |
| 1,139,220 | Institution | 0.73% | 34,381,660 | |
| 935,491 | Institution | 0.60% | 28,233,118 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 11,778,823 | Institution | 7.57% | 355,484,878 | |
| 1,731,392 | Institution | 1.11% | 52,253,411 | |
| 1,525,589 | Institution | 0.98% | 46,042,276 | |
| 1,436,749 | Institution | 0.92% | 43,361,085 | |
| 1,139,220 | Institution | 0.73% | 34,381,660 | |
| 935,491 | Institution | 0.60% | 28,233,118 | |
| 909,767 | Institution | 0.58% | 27,456,768 | |
| 718,814 | Institution | 0.46% | 21,693,807 | |
| 708,222 | Institution | 0.45% | 21,374,140 | |
| 490,169 | Institution | 0.31% | 14,793,300 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 8,559,592 | Institution | 5.50% | 254,562,266 | |
| 4,329,154 | Institution | 2.78% | 150,654,559 | |
| 3,717,982 | Institution | 2.39% | 112,208,697 | |
| 3,696,149 | Institution | 2.37% | 109,923,471 | |
| 3,513,997 | Institution | 2.26% | 122,287,096 | |
| 1,999,404 | Institution | 1.28% | 69,579,259 | |
| 1,932,901 | Institution | 1.24% | 67,264,955 | |
| 1,278,865 | Institution | 0.82% | 38,596,146 | |
| 1,237,450 | Institution | 0.79% | 37,346,241 | |
| 1,223,722 | Institution | 0.79% | 36,393,492 |
FAQ
Who Owns TG Therapeutics (TGTX)?
According to the latest TipRanks data, approximately 0.20% of the company's stock is held by institutional investors, 1.09% is held by insiders, and 58.14% is held by retail investors.
What percentage of TG Therapeutics (TGTX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.20% of TG Therapeutics (TGTX) stock is held by institutional investors.
What percentage of TG Therapeutics (TGTX) stock is held by retail investors?
According to the latest TipRanks data, approximately 58.14% of TG Therapeutics (TGTX) stock is held by retail investors.
Who owns the most shares of TG Therapeutics (TGTX)?
iShares owns the most shares of TG Therapeutics (TGTX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.